EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fraxin Attenuates Rheumatoid Arthritis by Regulating Macrophage Polarization and Inhibiting Fibroblast-like Synoviocyte Proliferation

Anjing Xu, Bao Hou, Shijie Zhang, Xiaoyue Ma, Yuanyuan Wen, Xuexue Zhu iD, Weiwei Cai, Jing Chen, Ma Mi, Tsedien Nhamdrie, Liying Qiu, Haijian Sun iD und 1 weitere

International Journal of Molecular Sciences · 24.03.2026 · 27 (7) · 2946

DOI: 10.3390/ijms27072946 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.03.2026. Verfasst von Anjing Xu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Jiangnan University Medical Center (Wuxi No. 2 People's Hospital), Wuxi School of Medicine, Jiangnan University, Wuxi 214…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Synoviocytes, Macrophages, Fibroblasts. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of China, High-level introduction of talents and scientific research start-up funds of JNU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Wuweiganlu (WGL) is a traditional formulation widely applied in the treatment of rheumatoid arthritis (RA), yet the identity of its bioactive constituents remains inadequately defined. In this study, ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS) and untargeted serum metabolomics were employed to characterize the active components of WGL. Fraxin was identified as a principal compound from WGL. To investigate its therapeutic mechanism in RA, a series of in silico and experimental approaches were conducted. Network pharmacology analysis and RNA sequencing identified heat shock protein family member 8 (HSPA8) as a potential molecular target of Fraxin, which was further validated by molecular docking studies. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses indicated that Fraxin exerts its effects primarily by modulating cell apoptosis through the PI3K signaling pathway. In vitro experiments demonstrated that Fraxin significantly reduced inflammatory responses and downregulated HSPA8 expression in lipopolysaccharide (LPS)-stimulated fibroblast-like synoviocytes (FLs) and macrophages. In vivo, Fraxin administration markedly reduced paw swelling, alleviated bone deformities, and improved bone volume fraction (BV/TV) in male IL1RA-deficient mice exhibiting spontaneous arthritis. Histological analysis confirmed that Fraxin attenuated joint inflammation by modulating the inflammatory microenvironment. Additionally, Fraxin inhibited synovial hyperplasia by regulating mitochondrial membrane potential collapse in FLs. Functional assays revealed that this regulation occurred via the inhibition of HSPA8/PI3K/AKT signaling axis, thereby suppressing aberrant FLS proliferation and contributing to the attenuation of RA progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidSynoviocytesMacrophagesFibroblastsAnimalsMiceCell ProliferationMaleSignal TransductionApoptosisHSC70 Heat-Shock ProteinsHumansMolecular Docking SimulationPhosphatidylinositol 3-KinasesCoumarins

Stichwörter der Autor:innen

FraxinHSPA8fibroblast-like synovial cellnetwork pharmacologyrheumatoid arthritis

Substanzen

fraxinHSC70 Heat-Shock ProteinsPhosphatidylinositol 3-KinasesCoumarins

Autor:innen und Institutionen

  • Department of Rheumatology, Jiangnan University Medical Center (Wuxi No. 2 People's Hospital), Wuxi School of Medicine, Jiangnan University, Wuxi 214002, China.
  • MOE Medical Basic Research Innovation Center for Gut Microbiota and Chronic Diseases, School of Medicine, Jiangnan University, Wuxi 214122, China.
  • Department of Basic Medicine, Wuxi School of Medicine, Jiangnan University, Wuxi 214122, China.
  • Department of Basic Medicine, Tibet University of Medicine, Lhasa 850000, China.
  • State Key Laboratory of Natural Medicines, China Pharmaceutical University, No. 24 Tongjia Lane, Nanjing 210009, China.

ORCID-Profile: Xuexue Zhu, Haijian Sun

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of China
  • High-level introduction of talents and scientific research start-up funds of JNU
  • Tibetan medicine 14th Five-Year Plan connotation construction project
  • Wuxi Association for Science and Technology 2024 Soft Project

Zitieren

APA

Xu, A., Hou, B., Zhang, S., Ma, X., Wen, Y., Zhu, X., Cai, W., Chen, J., Mi, M., Nhamdrie, T., Qiu, L., Sun, H., & Hua, M. (2026). Fraxin Attenuates Rheumatoid Arthritis by Regulating Macrophage Polarization and Inhibiting Fibroblast-like Synoviocyte Proliferation. International Journal of Molecular Sciences, 27(7), 2946. https://doi.org/10.3390/ijms27072946

Vancouver

Xu A, Hou B, Zhang S, Ma X, Wen Y, Zhu X, et al. Fraxin Attenuates Rheumatoid Arthritis by Regulating Macrophage Polarization and Inhibiting Fibroblast-like Synoviocyte Proliferation. International Journal of Molecular Sciences. 2026;27(7):2946. doi:10.3390/ijms27072946

BibTeX
@article{Xu2026,
  author = {Xu, Anjing and Hou, Bao and Zhang, Shijie and Ma, Xiaoyue and Wen, Yuanyuan and Zhu, Xuexue and Cai, Weiwei and Chen, Jing and Mi, Ma and Nhamdrie, Tsedien and Qiu, Liying and Sun, Haijian and Hua, Minhui},
  title = {Fraxin Attenuates Rheumatoid Arthritis by Regulating Macrophage Polarization and Inhibiting Fibroblast-like Synoviocyte Proliferation},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {7},
  pages = {2946},
  doi = {10.3390/ijms27072946}
}
Kostenlos starten →